| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_XPO1_0015400 | Exon-Exon | chr2:61721029-61724103 | chr2:61493894-61496968 | 447 nt | 0.3691 |
| hsa_XPO1_0015500 | Exon-Exon | chr2:61721029-61725927 | chr2:61493894-61498792 | 606 nt | 0.3680 |
| hsa_XPO1_0015600 | Exon-Exon | chr2:61721029-61753656 | chr2:61493894-61526521 | 108 nt | 0.3704 |
| hsa_XPO1_0015300 | Intron-Exon-Intron | chr2:61721029-61761813 | chr2:61493894-61534678 | 2026 nt | 0.3731 |
| hsa_XPO1_0015700 | Exon-Exon | chr2:61721029-61764803 | chr2:61493894-61537668 | 198 nt | 0.3889 |
| hsa_chr2_0891500 | Intergenic-Intergenic | chr2:61721095-61724047 | chr2:61493960-61496912 | 34 nt | 0.3529 |
| hsa_XPO1_0016600 | Exon-Exon | chr2:61722590-61724142 | chr2:61495455-61497007 | 288 nt | 0.3576 |
| hsa_XPO1_0016700 | Exon-Exon | chr2:61722590-61725927 | chr2:61495455-61498792 | 126 nt | 0.3651 |
| hsa_XPO1_0016800 | Exon-Exon | chr2:61722590-61729175 | chr2:61495455-61502040 | 204 nt | 0.3235 |
| hsa_XPO1_0016900 | Intron-Exon-Intron | chr2:61722590-61747610 | chr2:61495455-61520475 | 188 nt | 0.4574 |
A study in humans demonstrated that circXPO1 is highly expressed in early stages of hepatocellular carcinoma, bladder cancers, and breast cancer, and its decreased expression in myocardial tissues is associated with improved cardiac function after acute myocardial infarction [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in human coronary artery samples from a single autopsy case demonstrated that circXPO1 was identified as a co-overexpressed circRNA in both the left anterior descending and right coronary artery samples, classifying it as a potential biomarker associated with coronary atherosclerosis [Hou et al. DOI:10.1002/jcla.23552].